Compounding Today Newsletter

	King Guide to Parenteral Admixtures
	Standard Operating Procedures
	Formulas
	Physicochemical
	Flavorings
	Discontinued Products Database
	Filter Membrane Compatibility
	Oral Vehicles
	Base-Salt-Ester Weight Conversion
	NaCl Equivalent Values
	Veterinary Transdermals
	pH Adjustment
	Chemotherapy Vial Reconstitution and Stability
	Preservatives and Antioxidants
	Article Search

Interactive Claim Form

* Disclaimer


		International Journal of Pharmaceutical Compounding Volume 26, Number 6

Table of Contents

DEPARTMENTS

Prescription: Compounded Drugs Often Become Manufactured Drugs

Calculations: Strength, Specific Gravity, Conversions

FEATURE ARTICLES

Advanced Compounding: Compounding with Biotechnology Products, Part 2: Product-specific Considerations

Veterinary Compounding: Unlicensed Transdermal Medications in Feline Patients: Three Case Reports

Clinical Compounding: Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies

Formulation Support: A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing (See Questions Related to this Manuscript Below)

APPLIED COMPOUNDING

Advanced Compounding: Compounding With Microneedle Arrays, Part 2: Preparation and Administration Methods

Sterile Compounding: Contamination Control Strategies, Part 2

PEER REVIEWED

Formulative: Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dissolution

Other: Intravenous Physical Compatibility of Heparin Sodium and Furosemide

FORMULATIONS

Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion

Curcumin 2% Topical Gel

Diazoxide 10 mg-mL in Oral Mix SF

Enrofloxacin 11.35 mg-mL in Ora-Blend, Veterinary

Flucytosine 50 mg-mL in Ora-Sweet and Ora-Plus

Granisetron Hydrochloride 0.05 mg-mL in Ora-Sweet and Ora-Plus

Miller's Modified Mouthwash

Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding)

QUESTIONS RELATED TO THE ARTICLE "A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing"

Which clinical criteria differentiate acute wounds from chronic wounds?
What is the role of biofilm in external wound infection?
Which percent of weekly reduction in dermal-wound area represents normal healing?
Is systemic antibiotic prophylaxis of value in controlling burn-wound sepsis?
Which amino acid should not be incorporated into compounds used to treat chronic venous stasis ulcers?

Get a free digital sample, search 25 years of content, and subscribe today to IJPC - The only journal solely dedicated to the art and science of pharmaceutical compounding!

Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition

Did You Know (On Legacy) ...

...the following?

"One cannot leave a better legacy to the world than a well-educated family." (Thomas Scott)

Thoughts for the Week (On Honesty)

"Money dishonestly acquired is never worth the cost, while a good conscience never costs as much as it is worth." (J.P. Senn)

"If parents want honest children, they should be honest themselves." [Anon]

Get a Sample of IJPC

Get a free digital sample issue of the International Journal of Pharmaceutical Compounding - the only journal solely dedicated to compounding - at IJPC.com/FreeSample

Like what you see? Subscribe today to receive the latest digital issue and be in time to get the May/June 2022 print issue delivered to your door!

From Out of the Past

The wolf
Is shaved
So neat and trim
Red Riding Hood
Is now chasing him!
Burma-Shave


Copyright 2022 IJPC Inc. 122 N Bryant Ave, Edmond OK 73034		Manage my Email: Subscribe / Remove from List	Comments or Questions: info@compoundingtoday.com
	Reprints & Permissions: Reprints@ijpc.com